Mr. Serio, a partner in the Boston office of Seyfarth Shaw LLP, is a registered patent attorney concentrating his practice in the area of intellectual property concerning biotechnology, pharmaceuticals, medical devices, chemistry, and analytical scientific equipment. His practice involves drafting and prosecution of patents, right to use and patentability opinions, patent litigation, licensing of technology, and trademark issues.

Mr. Serio also has significant expertise in Food and Drug Law involving both pharmaceuticals and medical devices and in particular the FDA approval and marketing of therapeutic products and labeling of food and dietary supplements. He advises companies on a wide variety of regulatory issues, including, the national and international conduct of clinical studies, manufacturing, and FDA enforcement matters. He is a recognized expert on Direct to Consumer advertising of pharmaceuticals. He further assists clients in the preparation and filing of regulatory documents related to new drug applications, abbreviated new drug applications and 505(b)(2) applications. 

As a licensed pharmacist, Mr. Serio has a multilateral understanding of complex scientific principles and drug development within the pharmaceutical industry. He is an accredited speaker with the American College of Pharmaceutical Education and has written and lectured extensively on a variety of FDA and patent related topics. 

Mr. Serio, a partner in the Boston office of Seyfarth Shaw LLP, is a registered patent attorney concentrating his practice in the area of intellectual property concerning biotechnology, pharmaceuticals, medical devices, chemistry, and analytical scientific equipment. His practice involves drafting and prosecution of patents, right to use and patentability opinions, patent litigation, licensing of technology, and trademark issues.

Mr. Serio also has significant expertise in Food and Drug Law involving both pharmaceuticals and medical devices and in particular the FDA approval and marketing of therapeutic products and labeling of food and dietary supplements. He advises companies on a wide variety of regulatory issues, including, the national and international conduct of clinical studies, manufacturing, and FDA enforcement matters. He is a recognized expert on Direct to Consumer advertising of pharmaceuticals. He further assists clients in the preparation and filing of regulatory documents related to new drug applications, abbreviated new drug applications and 505(b)(2) applications. 

As a licensed pharmacist, Mr. Serio has a multilateral understanding of complex scientific principles and drug development within the pharmaceutical industry. He is an accredited speaker with the American College of Pharmaceutical Education and has written and lectured extensively on a variety of FDA and patent related topics.